Company Profile
Updated: 09-DEC-09Richter-Helm Biologics Gmbh
International Private company
Dengelsberg, Bovenau, 24796, Germany
()43311230101, 43311230100 fax,
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Commercial Physical Research
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Athera Receives Allowance of Two Key Patents.
Biotech Week; 10/28/2009; 874 words; ...Acute Coronary Syndrome and who are at imminent risk for Myocardial Infarction. Athera has an agreement with Richter-Helm BioLogics GmbH & Co. KG in Hamburg, Germany, for the process development of the product. Keywords: Atherosclerosis...
Antibody Fragment Production Breakthrough with 2nd Generation EBA.
Biotech Week; 5/27/2009; 852 words; Richter-Helm BioLogics GmbH & Co. KG announces a technological...from an E. coli expression system. Richter-Helm BioLogics has finalized the downstream...Having conducted a series of tests, Richter-Helm has discovered significant advantages...
Richter-Helm signs deal to develop Athera's ACS drug.
Pharma Marketletter; 1/26/2009; 503 words; Germany's Richter-Helm BioLogics GmbH has signed an agreement to develop and manufacture...Financial terms were not disclosed. Annexin A5 is a biologic produced using Richter-Helm's proprietary Escherichia coli-based expression...
Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease.
PR Newswire; 1/21/2009; 865 words; ...21 /PRNewswire/ -- Richter-Helm BioLogics GmbH & Co. KG and...product produced using Richter-Helm's proprietary...including TNO, Phadia GmbH and Johannes Gutenberg...Mail: k.pohlmeyer@richter-helm-biotec.eu; Contact...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning